What component of platelet-rich plasma delivers growth factors to the site of injury?

What Component of PRP Delivers Growth Factors to the Site of Injury

Platelet alpha-granules are the primary component in platelet-rich plasma that stores and delivers growth factors to the site of injury 1.

The Mechanism of Growth Factor Delivery

Platelet Alpha-Granules as the Primary Source

The platelets themselves—specifically their alpha-granules (α-granules)—serve as the storage depot for the vast array of growth factors and cytokines essential for wound healing 1. These granules contain:

• Platelet-derived growth factor (PDGF-AB and PDGF-BB)
• Transforming growth factor-beta1 (TGF-β1)
• Vascular endothelial growth factor (VEGF)
• Insulin-like growth factor-I (IGF-I)
• Fibroblast growth factor-basic (FGF-b)
• Epidermal growth factor (EGF)

1, 2, 3

The Release Process

Growth factors are released from platelets only upon platelet activation 1. The activation process can be triggered by:

• Thrombin
• Calcium chloride (re-calcification)
• Collagen exposure at the injury site

1, 4

This activation causes the alpha-granules to degranulate and release their bioactive proteins into the surrounding tissue 1.

Supporting Structural Components

The Fibrin Scaffold

Beyond the platelets themselves, PRP promotes development of a fibrin scaffold at the injury site that acts as a temporary matrix to assist tissue repair 1. This scaffold:

• Captures and maintains secreted growth factors at the application site
• Provides structural support for cellular migration
• Facilitates the wound healing cascade

1

Additional Cellular Contributors

While platelets are the primary source, leukocytes present in some PRP preparations (L-PRP) may also contribute to the regenerative environment through:

• Immune and antibacterial properties
• Additional growth factor regulation
• Tissue healing modulation

1

However, the role of leukocytes remains less well-defined compared to platelet-derived factors 1.

Clinical Implications

The concentration of platelets directly correlates with growth factor availability, with typical PRP preparations showing an 8-fold increase in platelet concentration compared to whole blood (from ~197 × 10³ to ~1600 × 10³ platelets/μL) 3. This translates to proportional increases in growth factors:

• PDGF-BB: increases from 3.3 ng/mL to 17 ng/mL
• TGF-β1: increases from 35 ng/mL to 120 ng/mL
• VEGF: increases from 155 pg/mL to 955 pg/mL

3

Important Caveat

Platelet count alone does not guarantee therapeutic efficacy 5. Functional platelet quality, donor biology (age, metabolic status, oxidative stress), and preparation methods significantly influence growth factor bioactivity and release 5, 6. Simply having high platelet numbers without proper activation or with compromised platelet function will not deliver optimal growth factor concentrations to the injury site.